These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7090750)

  • 21. Analysis of 2136 genetic amniocenteses: experience of a single physician.
    Hanson FW; Tennant FR; Zorn EM; Samuels S
    Am J Obstet Gynecol; 1985 Jun; 152(4):436-43. PubMed ID: 4014336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midtrimester amniocentesis and culture of aminiotic fluid cells.
    Huddleston JF; Carney FE
    Clin Obstet Gynecol; 1976 Dec; 19(4):941-56. PubMed ID: 991481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of ultrasound in evaluating problems and complications of genetic amniocentesis.
    McArdle CR; Cohen W; Nickerson C; Hann LE
    J Clin Ultrasound; 1983 Oct; 11(8):427-9. PubMed ID: 6417171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone levels in amniotic fluid and maternal serum in women who undergo spontaneous abortion after second trimester amniocentesis.
    Bremme K; Eneroth P; Nilsson B
    Gynecol Obstet Invest; 1984; 18(2):78-82. PubMed ID: 6479699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss.
    Wenstrom KD; Andrews WW; Tamura T; DuBard MB; Johnston KE; Hemstreet GP
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):830-3. PubMed ID: 8885730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal hyperechogenic bowel following intra-amniotic bleeding.
    Sepulveda W; Hollingsworth J; Bower S; Vaughan JI; Fisk NM
    Obstet Gynecol; 1994 Jun; 83(6):947-50. PubMed ID: 8190437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of fetal hemoglobin in amniocentesis contaminated with blood].
    Lerdo de Tejada A; Elisa Briones FB; Castelazo Morales E; Rviero Weber E; López García R; Karchmer S
    Ginecol Obstet Mex; 1978 Jul; 44(261):15-21. PubMed ID: 700399
    [No Abstract]   [Full Text] [Related]  

  • 28. Testosterone levels in midtrimester maternal and fetal plasma and amniotic fluid.
    Rodeck CH; Gill D; Rosenberg DA; Collins WP
    Prenat Diagn; 1985; 5(3):175-81. PubMed ID: 4022941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of amniocentesis.
    Brinsmead MW
    Med J Aust; 1976 Mar; 1(12):379-85. PubMed ID: 1272119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five hundred cases of amniocentesis without bloody tap.
    Katayama KP; Roesler MR
    Obstet Gynecol; 1986 Jul; 68(1):70-3. PubMed ID: 3523332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
    Brumfield CG; Cloud GA; Finley SC; Cosper P; Davis RO; Huddleston JF
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):822-5. PubMed ID: 2445206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal puncture during midtrimester amniocentesis.
    Karp LE; Hayden PW
    Obstet Gynecol; 1977 Jan; 49(1):115-7. PubMed ID: 831160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constriction of the umbilical cord by an amniotic band after midtrimester amniocentesis.
    Ashkenazy M; Borenstein R; Katz Z; Segal M
    Acta Obstet Gynecol Scand; 1982; 61(1):89-91. PubMed ID: 7090754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A report of early (13 + 0 to 14 + 6 weeks) and mid-trimester amniocenteses: 10 years' experience.
    Centini G; Rosignoli L; Kenanidis A; Scarinci R; Petraglia F
    J Matern Fetal Neonatal Med; 2003 Aug; 14(2):113-7. PubMed ID: 14629092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis.
    Kalogiannidis I; Prapa S; Dagklis T; Karkanaki A; Petousis S; Prapas Y; Prapas N
    Clin Exp Obstet Gynecol; 2011; 38(3):239-42. PubMed ID: 21995155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of pregnancy outcomes after second trimester amniocentesis between procedures performed by experts and non-experts.
    Wisetmongkolchai T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T; Jatavan P
    J Perinat Med; 2021 May; 49(4):474-479. PubMed ID: 33554581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and accuracy of midtrimester amniocentesis for prenatal diagnosis of genetic disorders.
    Aula P; Karjalainen O; Teramo K; Vaara L; Seppälä M
    Ann Clin Res; 1979 Aug; 11(4):156-63. PubMed ID: 92907
    [No Abstract]   [Full Text] [Related]  

  • 39. Midtrimester genetic amniocentesis. A review of the fetal risks.
    O'Brien WF
    J Reprod Med; 1984 Jan; 29(1):59-63. PubMed ID: 6708022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of amniocentesis in prolonged pregnancy.
    Green JN; Paul RH
    Obstet Gynecol; 1978 Mar; 51(3):293-8. PubMed ID: 628531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.